Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of LIZTOX Inj for Post Stroke Upper Limb Spasticity
NCT04415346Phase 1Unknown
- Sponsor
- Huons
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hutox in Upper limb spasticity, sponsored by Huons. Primary endpoint: Modified Ashworth Scale score improvement at 12 weeks. Status: unknown.
02
Drugs
hutox
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT04415346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415346.